Partnership to provide customers with direct access to portfolio of highly characterized hepatic cells to recreate advanced Liver-on-a-Chip assays
Pre-validated cells alleviate the need for stringent in-house quality control testing to maximize assay success
Cambridge, UK, 06 September 2023: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), and LifeNet Health LifeSciences, “LifeNet Health”, a non-profit, global leader in all-human research solutions, today announced a strategic partnership to supply…
AMSBIO has supplied a custom monoclonal antibody (mAB) to researchers at the TU Dortmund** in Germany to unravel the role of EDI3 in breast cancer development, its regulation by HER2 signalling, and its potential as a therapeutic target.
Characterized by the overexpression of the Human Epidermal growth factor Receptor 2 (HER2) - HER2+ breast cancer is a highly aggressive disease subtype. While HER2-targeted treatments have improved patient outcomes for this form of cancer, acquired and inherent resistance to these treatment remains a challenge, prompting…
Did you know...
Ireland's life sciences sector exports more than 45 billion Euros annually and employs over 50,000 people?
All but one of the world's 25 largest biotech and pharma companies have a presence in Ireland?
Ireland is the world's third largest exporter of pharmaceuticals and has over 50 FDA approved pharma and biopharma plants?
What can Biocair and Aramex Ireland do to support you?
They have a fully integrated service managed by the Aramex network with Biocair's expertise.
Creation and assistance with shipment paperwork and labelling to ensure a swift and compliant…
BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced that it will be showcasing its newly expanded ADME-Tox research capabilities at the 25th North American International Society for the Study of Xenobiotics (ISSX) Meeting, which will be held from September 10-13 in Boston, MA.
“We’re excited to be back in Boston to meet with the research community attending ISSX,” said Dr. Christopher Black, BioIVT Senior Vice President ADME-Tox. “At last year’s meeting, we announced that XenoTech had joined BioIVT, significantly expanding…
- Positive feedback from pre-IND meeting with FDA confirms Hikma’s continued development of AT307 under the 505(b)(2) regulatory pathway
- Abbreviated 505(b)(2) submission offers an efficient and streamlined development pathway with reduced risk
Cambridge, UK, 7th September 2023: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’s therapies to enable healthier lives, is pleased to announce further progress from Hikma in the development of ready-to-use ("RTU") injectable medicine AT307, following a recent positive pre-investigational new drug…
Read the September edition of eNews here, featuring:
► Welcome from Tony Jones, CEO
► What is the Importance of Training and Developing Your Workforce?
► Why is Working for a One Nucleus Member Company Good for You?
► Revitalising Conference Websites: Enhancing Engagement for Life Science Companies
► Are You Asking the Right Questions when Assessing Your Next Lab Space?
► New Horizons in Genetic Screening
One Nucleus and GTM Global Enter into Collaboration to Support Member International and Connectivity
One Nucleus and GTM Global Enter into Collaboration to Support Member International and Connectivity
Cambridge and London, UK, 05 September 2023
One Nucleus, the leading Life Science membership group supporting the translation of bio-innovation into successful businesses and ultimately patient benefit is delighted to announce the collaborative partnership with GTM Global (GTM), the unique online interactive ecosystem that engages with ambitious tech and digital scale-up businesses to expand internationally.
One Nucleus members will be able access GTM’s high-touch programme of…
Sign up to receive the latest regulatory updates from Boyds: https://boydconsultants.com/sign-up/
In this month's newsletter they shared recent guidance and key updates from the regulatory agencies:
Food and Drug Association (FDA)
European Medicines Agency (EMA)
Medicines and Healthcare products Regulatory Agency (MHRA)
European Commission (EC)
World Health Organisation (WHO)
On 5 October, Boyds is hosting a free webinar on 'How to successfully operationalize real-world data collection alongside expanded access programs', for more info and how to sign up, click here.
More than half the Cambridge startups [60.7%] listed in Seedtable’s ‘Startups in Cambridge to Watch’ list last month [July 2023] have already appeared on cofinitive’s #21toWatch list in previous years.
This timely revelation, as the nominations window for #21toWatch 2024 opens, confirms that the #21toWatch awards really do spotlight the brightest and best from across Cambridge and beyond.
#21toWatch recognises the outstanding people, companies and innovations in our region, providing high-level exposure and increasing opportunities for funding and investment for the winning candidates.
Every…
Check out and subscribe to the latest newsletter from Stevenage Bioscience Catalyst.
Highlights include:
UBS Asset Management and Reef Group secure approval for one of Europe's largest Life Sciences campuses in Europe
Cell and Gene Therapy, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapies
Plasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogenic cell immunotherapies
BioWednesday Stevenage: 6 September